Genetron Holdings Ltd
DelistedCIK 1782594fmd_1GD2TVZ6F6Q4BCGHD91QK8TA14Services · Services-Medical LaboratoriesTemplate: Standard
Coverage: Jan 01, 2018 to Dec 31, 2022, 5 periods
| Line item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| Total revenues | 225 | 323 | 424 | 532 | 651 |
| Cost of revenue | 132 | 178 | 164 | 194 | 369 |
| Gross profit | 93 | 145 | 260 | 338 | 281 |
| Research and development | 71 | 92 | 149 | 254 | 290 |
| Selling, general and administrative | 271 | 371 | 373 | 570 | 631 |
| Operating income | (233) | (307) | (268) | (518) | (702) |
| Interest expense | – | 12 | 6 | 5 | 111 |
| Income before taxes | (465) | (676) | (3,069) | (503) | (811) |
| Income tax expense | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | (465) | (676) | (3,069) | (503) | (811) |
| Net income | (465) | (676) | (3,069) | (496) | (808) |